AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14998812 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2100
Study 11220454 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophysiologic testing (EP)‐guided therapy with implantable defibrillator
Number of subjects: 0
Study 11220454 — intervention group
Group type: COMPARATOR
Intervention: Electrophysiologic testing (EP)
Number of subjects: 0
Study 8994421 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct NO donors (infusion of linsidomine followed by oral molsidomine)
Number of subjects: 700
Study 8994421 — intervention group
Group type: COMPARATOR
Intervention: Oral diltiazem
Number of subjects: 700
Study 8994421 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined major clinical events (death, nonfatal myocardial infarction, and coronary revascularization)
Number of subjects: 700
Study 7971288 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy x-ray absorptiometry (DXA) of the spine
Number of subjects: 556
Study 7971288 — intervention group
Group type: COMPARATOR
Intervention: Peripheral quantitative computed tomography (pQCT) of the distal radius
Number of subjects: 556
Study 3674276 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held weights
Number of subjects: 28
Study 3674276 — intervention group
Group type: COMPARATOR
Intervention: Non-hand-held weights
Number of subjects: 28
Study 30396627 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamon (1000 mg capsules)
Number of subjects: 0
Study 30396627 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1000 mg starch capsules)
Number of subjects: 0
Study 27276811 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal dural release during expansive cervical laminoplasty (group A)
Number of subjects: 32
Study 27276811 — intervention group
Group type: COMPARATOR
Intervention: Simple expansive cervical laminoplasty (group B)
Number of subjects: 32
Study 24798208 — intervention group
Group type: EXPERIMENTAL
Intervention: Arousing interest through an invitation
Number of subjects: 0
Study 24798208 — intervention group
Group type: EXPERIMENTAL
Intervention: Arousing interest on the website itself
Number of subjects: 0
Study 22196836 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy intervention (brief, nurse-delivered during hospitalization with a 1-week booster phone call)
Number of subjects: 41
Study 22196836 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 20200201 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers
Number of subjects: 10544
Study 17623604 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted TKA
Number of subjects: 52
Study 17623604 — intervention group
Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 52
Study 16360063 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Ventricular (LV) pacing
Number of subjects: 34
Study 16360063 — intervention group
Group type: COMPARATOR
Intervention: Biventricular (BiV) pacing
Number of subjects: 34
Study 16360063 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Ventricular (LV) pacing with ventricular fusion
Number of subjects: 34
Study 16360063 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Ventricular (LV) pacing without fusion
Number of subjects: 34
Study 12608624 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled anesthetics and/or radiation exposure
Number of subjects: 95
Study 12608624 — intervention group
Group type: COMPARATOR
Intervention: Control group (matched for maternal age and gestational age)
Number of subjects: 95
Study 9649457 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg AM and 20 mg PM) for 7 days
Number of subjects: 39
Study 9649457 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 7978090 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine (60‐mg oral dose)
Number of subjects: 19
Study 7978090 — intervention group
Group type: COMPARATOR
Intervention: Control group (12 healthy males)
Number of subjects: 19
Study 3263508 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 at 1 X 10(6) U/m2 per day
Number of subjects: 0
Study 3263508 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 at 3 X 10(6) U/m2 per day
Number of subjects: 0
Study 3263508 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous-infusion IL-2 at 3 X 10(6) U/m2 per day
Number of subjects: 0
Study 3263508 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined regimen (bolus and continuous IL-2) at 3 X 10(6) U/m2 per day
Number of subjects: 0
Study 3263508 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin added to IL-2 regimen
Number of subjects: 0
Study 31126554 — intervention group
Group type: EXPERIMENTAL
Intervention: Tung's acupuncture
Number of subjects: 60
Study 31126554 — intervention group
Group type: COMPARATOR
Intervention: Cyproterone acetate/ethinylestradiol (CPA/EE)
Number of subjects: 60
Study 27861459 — intervention group
Group type: COMPARATOR
Intervention: Waiting Group (WG; n = 16)
Number of subjects: 33
Study 27861459 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Group (DG; n = 17)
Number of subjects: 33
Study 27187105 — intervention group
Group type: EXPERIMENTAL
Intervention: IPC (ischemia cycles lasted 5 min)
Number of subjects: 30
Study 27187105 — intervention group
Group type: COMPARATOR
Intervention: SHAM (ischemia cycles lasted 1 min)
Number of subjects: 30
Study 24411642 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD group
Number of subjects: 55
Study 24411642 — intervention group
Group type: COMPARATOR
Intervention: Control group (typically developing students)
Number of subjects: 55
Study 22801017 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (Tsang‐Erh‐San extract granules and Houttuynia extract powder)
Number of subjects: 53
Study 22801017 — intervention group
Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 53
Study 22801017 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM)
Number of subjects: 53
Study 19351979 — intervention group
Group type: EXPERIMENTAL
Intervention: Regularized B-spline deformable registration for respiratory gated PET images
Number of subjects: 0
Study 19351979 — intervention group
Group type: EXPERIMENTAL
Intervention: Motion correction using the registration algorithm
Number of subjects: 0
Study 17549956 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric training
Number of subjects: 20
Study 15295372 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal fibronectin results available
Number of subjects: 0
Study 15295372 — intervention group
Group type: COMPARATOR
Intervention: Fetal fibronectin results not available
Number of subjects: 0
Study 11341338 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT + PTH(1-34) 400 U (25 microg) per day for 3 years
Number of subjects: 52
Study 11341338 — intervention group
Group type: COMPARATOR
Intervention: HRT alone
Number of subjects: 52
Study 9626828 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescue PTCA
Number of subjects: 198
Study 9626828 — intervention group
Group type: COMPARATOR
Intervention: Conservative management after failed thrombolysis
Number of subjects: 198
Study 9626828 — intervention group
Group type: COMPARATOR
Intervention: Successful thrombolysis
Number of subjects: 198
Study 7615228 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium phosphate-bisacodyl
Number of subjects: 147
Study 7615228 — intervention group
Group type: COMPARATOR
Intervention: PEG-ES lavage
Number of subjects: 147
Study 2197450 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcoital trimethoprim-sulfamethoxazole
Number of subjects: 27
Study 2197450 — intervention group
Group type: COMPARATOR
Intervention: Postcoital placebo
Number of subjects: 27
Study 955230 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-strength dimethylsulfoxide (DMSO) and potent topical corticosteroids
Number of subjects: 0
Study 955230 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower strengths of DMSO
Number of subjects: 0
Study 955230 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0
Study 31217178 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular (IM) diclofenac (75 mg)
Number of subjects: 300
Study 31217178 — intervention group
Group type: COMPARATOR
Intervention: Oral (PO) diclofenac (100 mg)
Number of subjects: 300
Study 26685923 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga and compassion meditation program (n=25), 8 weeks duration, 3 sessions per week, each lasting 1 hour and 15 minutes.
Number of subjects: 46
Study 26685923 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) (n=21), received no treatment.
Number of subjects: 46
Study 25882029 — intervention group
Group type: EXPERIMENTAL
Intervention: On-stimulation period (DBS active)
Number of subjects: 15
Study 25882029 — intervention group
Group type: COMPARATOR
Intervention: Off-stimulation period (DBS inactive)
Number of subjects: 15
Study 25882029 — intervention group
Group type: COMPARATOR
Intervention: Comparison of on-stimulation vs off-stimulation
Number of subjects: 15
Study 23377231 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral movement therapy
Number of subjects: 10
Study 23377231 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral movement therapy
Number of subjects: 10
Study 21952008 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (10-day regimen: 2 days prior to surgery and 7 days following)
Number of subjects: 70
Study 21952008 — intervention group
Group type: COMPARATOR
Intervention: Regular preoperative chemoprophylaxis (Control group)
Number of subjects: 70
Study 19656689 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 2.5% w/w Reseda luteola extract (s-RE)
Number of subjects: 50
Study 19656689 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 1% w/w
Number of subjects: 50
Study 19656689 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (glycerol)
Number of subjects: 50
Study 17403977 — intervention group
Group type: EXPERIMENTAL
Intervention: Low doses of olanzapine
Number of subjects: 12
Study 17403977 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of olanzapine
Number of subjects: 12
Study 17403977 — intervention group
Group type: EXPERIMENTAL
Intervention: Low doses of risperidone
Number of subjects: 12
Study 17403977 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of risperidone
Number of subjects: 12
Study 15526817 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide 200 microg plus formoterol 4.5 microg
Number of subjects: 1272
Study 15526817 — intervention group
Group type: COMPARATOR
Intervention: Budesonide 100 microg plus formoterol 4.5 microg
Number of subjects: 1272
Study 15526817 — intervention group
Group type: COMPARATOR
Intervention: Budesonide 200 microg alone
Number of subjects: 1272
Study 11298132 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine-lamivudine (ZDV-3TC)
Number of subjects: 70
Study 11298132 — intervention group
Group type: COMPARATOR
Intervention: No antiretroviral treatment
Number of subjects: 70
Study 9760814 — intervention group
Group type: COMPARATOR
Intervention: MCP-1 levels in urine
Number of subjects: 34
Study 9760814 — intervention group
Group type: COMPARATOR
Intervention: MCP-1 levels in serum
Number of subjects: 34
Study 1322780 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone iontophoresis (E)
Number of subjects: 18
Study 1322780 — intervention group
Group type: COMPARATOR
Intervention: Placebo iontophoresis (P)
Number of subjects: 18
Study 1322780 — intervention group
Group type: COMPARATOR
Intervention: No treatment (C)
Number of subjects: 18
Study 6733173 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral ECT
Number of subjects: 28
Study 6733173 — intervention group
Group type: COMPARATOR
Intervention: Unilateral ECT
Number of subjects: 28
Study 31059991 — intervention group
Group type: EXPERIMENTAL
Intervention: H1-coil
Number of subjects: 228
Study 31059991 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-coil
Number of subjects: 228
Study 31059991 — intervention group
Group type: COMPARATOR
Intervention: Control (standard-of-care pharmacotherapy alone)
Number of subjects: 228
Study 30566472 — intervention group
Group type: COMPARATOR
Intervention: Four-part intervention targeting routine work practices, department conditions, and faculty readiness over an 18-month period.
Number of subjects: 0
Study 27568890 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen in noninvasive ventilation group
Number of subjects: 302
Study 27568890 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen in continuous positive airway pressure group
Number of subjects: 302
Study 27568890 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen in lifestyle modification group
Number of subjects: 302
Study 27568890 — intervention group
Group type: COMPARATOR
Intervention: Supplemental oxygen across all groups
Number of subjects: 302
Study 23328710 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet with low-dose active vitamin D
Number of subjects: 309
Study 23328710 — intervention group
Group type: COMPARATOR
Intervention: Usual care without cinacalcet (Control)
Number of subjects: 309
Study 21193852 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-week weight control intervention delivered by classroom teachers
Number of subjects: 618
Study 21193852 — intervention group
Group type: COMPARATOR
Intervention: General health intervention (Control)
Number of subjects: 618
Study 19486273 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin treatment (daily use in 65% of children, occasional use in 12%)
Number of subjects: 94
Study 19486273 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin treatment
Number of subjects: 94
Study 19486273 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of melatonin treatment
Number of subjects: 94
Study 17728213 — intervention group
Group type: EXPERIMENTAL
Intervention: cagA-positive H. pylori infection
Number of subjects: 2145
Study 17728213 — intervention group
Group type: EXPERIMENTAL
Intervention: cagA-negative H. pylori infection
Number of subjects: 2145
Study 17728213 — intervention group
Group type: COMPARATOR
Intervention: Individuals with normal mucosa or superficial gastritis (control)
Number of subjects: 2145
Study 15271128 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed Up and Go test
Number of subjects: 456
Study 15271128 — intervention group
Group type: EXPERIMENTAL
Intervention: Step test
Number of subjects: 456
Study 15271128 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Reach test
Number of subjects: 456
Study 15271128 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral reach test
Number of subjects: 456
Study 11842864 — intervention group
Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate (1200 mg) and glucosamine hydrochloride (1500 mg) daily for 12 weeks
Number of subjects: 45
Study 11842864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 7640143 — intervention group
Group type: EXPERIMENTAL
Intervention: Tucaresol
Number of subjects: 12
Study 7640143 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2767021 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month home-based aerobic exercise training program
Number of subjects: 120
Study 2767021 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 120
Study 340133 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole
Number of subjects: 19
Study 340133 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole
Number of subjects: 19
Study 31918169 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory intervention
Number of subjects: 93
Study 31918169 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness training intervention
Number of subjects: 93
Study 31918169 — intervention group
Group type: COMPARATOR
Intervention: Wellness-focused control condition
Number of subjects: 93
Study 31918169 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory and distress tolerance
Number of subjects: 93
Study 31062834 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine, 15 mg/day (n=36)
Number of subjects: 108
Study 31062834 — intervention group
Group type: COMPARATOR
Intervention: Other common antidepressants (n=72)
Number of subjects: 108
Study 31062834 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine
Number of subjects: 108
Study 31062834 — intervention group
Group type: COMPARATOR
Intervention: Other common antidepressants
Number of subjects: 108
Study 28801386 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Management of Neonatal and Childhood Illness programme
Number of subjects: 60480
Study 25460261 — intervention group
Group type: EXPERIMENTAL
Intervention: Restorative Safety Behaviors (RSB)
Number of subjects: 67
Study 25460261 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive Safety Behaviors (PSB)
Number of subjects: 67
Study 25460261 — intervention group
Group type: COMPARATOR
Intervention: No Safety Behaviors (NSB)
Number of subjects: 67
Study 23728991 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education requests regarding emotional distress
Number of subjects: 374
Study 23728991 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education requests regarding rehabilitation
Number of subjects: 374
Study 23728991 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education requests regarding disease symptoms
Number of subjects: 374
Study 23728991 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education requests regarding nutritional support
Number of subjects: 374
Study 23728991 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education requests regarding sexual health
Number of subjects: 374
Study 21560476 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct intramyocardial injection of autologous bone marrow cells (CD34+ selected cells)
Number of subjects: 0
Study 21560476 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct intramyocardial injection of autologous bone marrow cells (all mononuclear cells)
Number of subjects: 0
Study 21560476 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct intramyocardial injection of autologous bone marrow cells (both CD34+ selected cells and all mononuclear cells)
Number of subjects: 0
Study 19702080 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixu Jieyu Recipe (LJR), 100 mL twice a day for 3 months
Number of subjects: 75
Study 19702080 — intervention group
Group type: COMPARATOR
Intervention: Vitamin B tablets (10 mg twice a day), adenosine triphosphate (ATP, 20 mg thrice a day), and Oryzanol tablets (20 mg thrice a day)
Number of subjects: 75
Study 19702080 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixu Jieyu Recipe (LJR)
Number of subjects: 75
Study 19702080 — intervention group
Group type: COMPARATOR
Intervention: Control group (Vitamin B, ATP, Oryzanol)
Number of subjects: 75
Study 16814691 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple Random Staircase (MRS)
Number of subjects: 65
Study 16814691 — intervention group
Group type: COMPARATOR
Intervention: Tender point count
Number of subjects: 65
Study 16814691 — intervention group
Group type: COMPARATOR
Intervention: Dolorimetry
Number of subjects: 65
Study 12919762 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal mupirocin combined with octenidine dihydrochloride bodywash over a period of five days
Number of subjects: 32
Study 10700487 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM) program
Number of subjects: 60
Study 9061154 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard PACU rewarming intervention (two warmed thermal blankets and a hospital bedspread)
Number of subjects: 0
Study 9061154 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard PACU rewarming intervention plus a reflective blanket
Number of subjects: 0
Study 9061154 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard PACU rewarming intervention plus a reflective blanket and a reflective head covering
Number of subjects: 0
Study 8202722 — intervention group
Group type: COMPARATOR
Intervention: rHuEPO 100 U/kg subcutaneously three times per week for up to 8 weeks
Number of subjects: 413
Study 8202722 — intervention group
Group type: COMPARATOR
Intervention: rHuEPO 150 U/kg subcutaneously three times per week for 12 weeks
Number of subjects: 413
Study 8202722 — intervention group
Group type: COMPARATOR
Intervention: rHuEPO treatment in responding patients
Number of subjects: 413
Study 8202722 — intervention group
Group type: EXPERIMENTAL
Intervention: rHuEPO therapy overall
Number of subjects: 413
Study 3223250 — intervention group
Group type: EXPERIMENTAL
Intervention: Adeno‐tonsillectomy
Number of subjects: 150
Study 3223250 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenoidectomy
Number of subjects: 150
Study 3223250 — intervention group
Group type: COMPARATOR
Intervention: Neither procedure (Control)
Number of subjects: 150
Study 31735996 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper limb pure eccentric training for 6 weeks
Number of subjects: 21
Study 31735996 — intervention group
Group type: COMPARATOR
Intervention: No additional exercise during 6 weeks
Number of subjects: 21
Study 30278335 — intervention group
Group type: EXPERIMENTAL
Intervention: Feed-forward on drafts
Number of subjects: 118
Study 30278335 — intervention group
Group type: COMPARATOR
Intervention: Feed-forward on outlines
Number of subjects: 118
Study 28608311 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 600 mg administered 24 hours before and immediately before the procedure
Number of subjects: 0
Study 28608311 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered 24 hours before and immediately before the procedure
Number of subjects: 0
Study 28608311 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 600 mg
Number of subjects: 0
Study 26272499 — intervention group
Group type: EXPERIMENTAL
Intervention: Agenda form
Number of subjects: 0
Study 26272499 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 23808786 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulant medication
Number of subjects: 32
Study 23808786 — intervention group
Group type: COMPARATOR
Intervention: Neurofeedback (NF)
Number of subjects: 32
Study 21258075 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan (12 µg bolus followed by an infusion of 0.2 µg kg(‐1) min(‐1))
Number of subjects: 24
Study 21258075 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 19797993 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen
Number of subjects: 0
Study 19797993 — intervention group
Group type: COMPARATOR
Intervention: Breathing 14.1% oxygen (hypoxia)
Number of subjects: 0